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Renal supportive care in Taiwan 491care main program. We focused on understanding the need and providing the choice of RSC to
suitable candidates. A three-step and four-phase protocol was designed and implemented to
identify appropriate patients and to enhance the applicability of the RSC. We harnessed family
visit and home-based family meeting as a vehicle to understand the patients’ preferences, to
discover what ESRD patients and their family value most, and to introduce the option of RSC. In
the current review, we described our pilot experience of establishing a RSC program in Taiwan,
and discuss its potential advantage.
Copyright ª 2016, Formosan Medical Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Introduction
The prevalence of chronic kidney disease (CKD) is esti-
mated at 7% among persons who are in their thirties or
older, increasing to 23e36% among the elderly.1 The
healthcare cost of patients with CKD and end-stage renal
disease (ESRD) confers significant burden to the existing
healthcare system; administrative data disclose that caring
for ESRD patients is responsible for nearly 2% of all
healthcare expenditure.2 Apart from its economical
impact, the presence of CKD/ESRD and their predecessor,
acute kidney injury (AKI), all increase the risk of adverse
patients outcomes but can be partially ameliorated by
multidisciplinary CKD care.3,4
Other than the hard endpoints including hospitalization
rates and survival, patient-reported outcomes (PROs) in
patients with CKD/ESRD have drawn increasing attention.
PROs, including health-related quality of life (HRQoL),
symptom-scoring indices, and self-rated health status, are
defined as measurements based on reports coming directly
from patients without the amendment or interpretation by
the clinicians.5 Components of PROs and subjective symp-
toms of CKD/ESRD patients have already been validated as
factors strongly associated with patient survival and renal
outcomes.6 In addition, assessment of PROs potentially im-
proves patient care, enhances our understanding of patient
preferences, and most important of all, aids in the decision-
making processes of patients and physicians.7,8 Moreover,
existing treatments proven to provide survival benefits in
CKD/ESRD patients might not offer similar improvement in
PROs. Patients with ESRD, unlike those with failure of other
vital organs, enjoy reasonable life expectancy beyond years,
thanks to the advancement in renal replacement therapies;
nonetheless, they are particularly prone to suffer from
adverse symptomatology over their lives after dialysis initi-
ation.9 Therefore, for ESRD patients, PROs emerge as
important outcomes alternative to patient survival. Weigh-
ing the importance of survival against PROs becomes an
important issue during the care of CKD/ESRD patients.
Dilemma of CKD/ESRD patients: pros and cons
of dialysis
The course of dialysis, including hemodialysis and perito-
neal dialysis, is often fraught with discomfort of different
severities.9,10 The accessibility and convenience of main-
tenance dialysis significantly prolongs the survival among
ESRD patients. However, this extension in life is not withoutcost; ESRD patients frequently have complex comorbidities
and high symptom burdens. Local studies identify that
35e70% of ESRD patient have comorbid hypertension, dia-
betes mellitus, or heart failure, all of which potentially
compromise their functional status.11,12 A U.S. study
revealed that patients in their seventies commencing renal
replacement therapies have an estimated 1- and 5-year
survival of 50% and 15%, compared to 75% and 35% in dial-
ysis patients without age specifications, whereas in Taiwan,
the number could lie somewhere between 70e80% and
40e50%, respectively.13,14 Among their dialysis career,
studies from Western countries reported that an average of
71% suffer from fatigue, whereas 50% are plagued by uremic
pruritus, constipation, anorexia, and pain from multiple
sites; in Taiwan, cross-sectional studies similarly reported
that fatigue, dry mouth, and muscular weakness occur in
more than 50% of dialysis patients.10,15 Intradialytic hypo-
tension is particularly common in these vulnerable pa-
tients.16 Consequently, the reduction of discomfort
assumes higher priority than maintaining their lives, at
least for some of these patients. Physicians caring for
elderly with advanced CKD/ESRD should balance between
traditional therapeutic goals (renal and overall survival)
and the PROs (QoL, symptom severity) at the same time.
Trajectories of survival in elderly patients with
CKD/ESRD
The dilemma in choosing the best therapies for elderly CKD/
ESRD patients also stems from the ambiguity in estimating
their prognosis. The trajectories to death differ between
ESRD and other terminal illnesses. From the clinicians’
perspective, the clinical courses of patients with renal failure
could be rather indolent compared to those of the other dis-
eases, and the “turning point” of the rapid involution toward
mortality might be obscure.17 From patients’ view, they also
report that “an unexpected turn occurs when they develop
ESRD from diabetic nephropathy.”18 It is no wonder that the
mixed feelings frommultimorbidity, diverse symptomatology,
and an uncertainty about their lives frequently prompts
these elderly to forgo or discontinue their dialysis carrier.
Renal palliative care/renal supportive care in
Taiwan: why?
Palliative care for advanced CKD and ESRD patients, or
renal supportive care (RSC), provides multifaceted assis-
tance to suitable candidates that value quality more than
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sumes priority over survival for these patients. Discomfort
reported by ESRD patients arises partially from dialysis per
se, and the interruption or discontinuation of such therapy
could potentially improve their QoL.19 Palliative care,
recognized as “both patient- and family-centered care
that optimizes QoL by anticipating, preventing, and
treating suffering,” becomes increasingly important when
disease cure seems unattainable.20 This is particularly true
for the comorbidity-ridden ESRD patients, for whom dial-
ysis undoubtedly prolongs their lives but does not improve
or even worsens the PROs.21,22 In fact, dialysis withdrawal
is currently the second to third common cause of mortality
among ESRD patients from developed countries (around
3.5 case per 100 patient-year), and there are guidelines or
positional statements from professional societies, detail-
ing the why, who, and how to implement RSC
(Figure 1).23,24 By contrast, the spread and adoption of RSC
in Asian countries has been slow, including Taiwan. The
Dialysis Outcomes and Practice Patterns Study found that
in Japan, the rate of dialysis withdrawal is significantly
lower than that in Western countries.25 Although the
introduction of hospice/palliative care in Taiwan began
25 years ago, the expansion of the hospice/palliative care
to cover ESRD patients began only after 2010 (Figure 2).
The first expert meeting on domestic palliative care model
in ESRD patients reached preliminary consensus, but de-
tails on selecting the appropriate enrollees were highly
debated, in light of the cultural issues among Taiwanese
people and other concerns.26 Currently, the government,
the academic societies, the clinicians, and the patient
groups are exerting concerted efforts to increase the
feasibility of RSC in Taiwan. However, much more is still
needed along the path.Figure 1 The diagram illustrating the recommended potential
professional societies of United States (left circle) and Australia/N
the subpopulation that both guidelines recognize to be suitable for
comorbidity index; FSZ functional status; RSCZ renal supportivePrior to establishing the domestic RSC
pathway, we could.?
The importance of RSC in appropriate candidates cannot be
overstated, as PROs frequently outweigh patient survival
among the preferences of advanced CKD/ESRD patients,
especially the elderly ones. We have recognized three
important issues that need to be considered when evalu-
ating the applicability of a RSC pathwaydthat is, the
ruraleurban differences, the uncertainty in prognosis esti-
mation for aged renal patients, and the inherent sociocul-
tural issues in Taiwan.Ruraleurban differences
Differences in several aspects exist between rural and
urban residents with CKD/ESRD, as geographic separation
has been found to negatively influence clinical outcomes.
Studies identified that residential locations could impact
the accessibility to predialysis care, whereas facility
properties as well as patient educational levels are all
outcome determinants in CKD/ESRD patients.27 Our
experience concurs that an incrementally inverse rela-
tionship exists between the distance to dialysis facilities
and serum albumin/hemoglobin levels in chronic dialysis
patients.28 The potential mediators of this association
include the healthcare accessibility, the timeliness of
medical events recognition, or the literacy for health
knowledge. Judging from this, a domestic RSC program
might have different penetration rates between rural and
urban areas.
Critical knowledge gaps can exist between rural and
urban residents regarding RSC. The unfamiliarity with RSCcandidates for receiving RSC among different guidelines from
ew Zealand (right circle). The central ellipsoid area represents
receiving RSC. ACPZ advanced care planning; CCIZ Charlson
care; SQZ surprise question.
Figure 2 Timelines depicting the temporal trend of palliative/hospice care program establishment and the Taiwan NHI reim-
bursement schemes change. ESRDZ end-stage renal disease; MVZmechanical ventilation; NHIZ National Health Insurance;
TSNZ Taiwan Society of Nephrology.
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internists, and laypersons might lead to misunderstanding
when medical communication takes place.29 Interdisci-
plinary effort is often required to facilitate discussions
about end-of-life (EOL) care in a need-oriented way,30 but
dedicated specialists including psychologists and social
workers are frequently lacking in rural areas. The patient/
physician ratio is also higher in the geographically remote
regions, reducing the time each physician can spend in
interview or family meeting. Finally, its takes longer time
for older and noncancer terminal patients to understand
the option of RSC than for younger ones, which occupies a
lower percentage of the rural population.30 Both local
studies and those from other countries found that decision-
making processes are often suboptimal in older and
noncancerous patients being hospitalized.31,32 Aging pa-
tients are frequently impaired in their communicative
ability owing to the visual and auditory dysfunction,
requiring proxies for assistance in decision-making. Infer-
ring their true wishes poses another challenge if we want to
successfully establish a domestic RSC program.33
Despite the abovementioned concerns, there are advan-
tages for starting an RSC program in rural areas. In our
experience, rural residents maintain a better relationship
with their primary care physicians owing to a deep-rooted
acquaintance. Rural Taiwanese patients, especially those of
advanced age, tend to completely rely on physicians tomake
recommendations on treatment options, with little personal
input. Furthermore, we also found that rural elderly patients
place more emphasis on their symptom burden than on the
duration of survival, compared to their urban counterparts.
These features should be factored into consideration prior to
implementing the RSC program in different areas.Prognosis estimation
To accurately estimate the duration of survival as possible
in advanced CKD/ESRD patients is the cornerstone for all
RSC programs; such estimation provides suitable candidates
with a reasonable expectation of their life span, based on
which medical decisions can be made. Domestic studies
identified that terminally ill patients with inaccurate
prognostic awareness are more likely to be undecided upon
invasive life-sustaining treatments.34 Existing RSC guide-
lines suggest different prognosis-estimation formulae,23,24
and the core variables include age, comorbidity, nutri-
tional status, and functional levels, aided by the “surprise
question.” Modified Charlson score, prognostic scores by
Couchoud et al35 and Cohen et al36 are the most common
tools for prognosis prediction in predialysis and chronic
dialysis patients. However, none of these formulae derive
from a predominantly Asian population, and the accuracy
among Taiwanese patients is unknown. Consequently, a
domestic prognosis-estimation formula in patients with
advanced CKD/ESRD would be beneficial. Kan et al37 have
conducted a pilot study on this issue by designing a new
comorbidity index system for elderly dialysis patients, using
Taiwan National Health Insurance database analysis. How-
ever, more studies are needed to validate its utility, and
modification of this formula with the incorporation of other
variables would be anticipated in the future.Sociocultural issue in Taiwanese society
The discussions surrounding EOL care is frequently avoided
consciously or subconsciously in Taiwan.26,32,33 Family
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care as taboos that will bring bad luck to their sick rela-
tives. The responsibility of medical decision-making often
falls on the patients’ bloodlines or spouses, called “Family-
centered decision-making model.”26 Domestic studies re-
ported that among a large cohort of oncology patients, only
22.6% signed their own Do-Not-Resuscitate (DNR) orders,
and 67.6% of the DNR forms signed by patients were
incomplete, compared to 81.7% by their surrogate(s).38 This
exemplifies the phenomenon that in Taiwan, disclosure of
the terminal status is potentially unpleasant for family
members or sometimes for patients; in response, medical
decision-making is often accomplished by patients’ surro-
gates.39 For patients with advanced CKD/ESRD, the unde-
termined prognosis and the family-centered model might
prompt physicians to avoid telling the truth to patients,
potentially interfering with the implementation of the RSC
program.
Implementation of RSC in Taiwan: how?
A successful RSC program can potentially relieve patient
suffering, enhance both patient and family satisfaction,
and ultimately reduce unnecessary healthcare spending.40
However, in Taiwan, very few have addressed the issue of
successfully implementing a domestic RSC program.
National Taiwan University Hospital Jinshan branch
(NTUH-JS) is a community hospital in the rural outskirt of
New Taipei City.28 Supported by its main branch, a tertiary
referral center, NTUH-JS has initiated a community-based
palliative/hospice care program since 2012, with an
outreach RSC subprogram aiming to offer the best con-
servative management for rural residents covered by
NTUH-JS medical service. We will briefly overview our 4-
year experience in advancing the RSC subprogram in the
following section, from how to recognize potential candi-
dates, to the three-step/four-phase care structures we
provided.
Identification of appropriate candidates for RSC
Who will benefit the most from RSC has been the center of
debate in the literature. Most clinicians agree that fully
informed patients with decision-making capacity and when
making voluntary choices about refusing dialysis or
requesting to discontinue dialysis are suitable candidates;
those with previous explicit expressions of such wills in the
form of advance directives, or with properly appointed
surrogates, would also be candidates for RSC. However,
apart from these commonalities, significant disparities
emerge in the indications of RSC between countries
(Figure 1). For example, the U.S. version places more
emphasis on neurological and extrarenal conditions,
whereas the Australian/New Zealand version provides
phenotype-based descriptions of suitable candidates. In
Taiwan, a formal consensus has not been unanimously
reached, but adaptations of criteria for RSC candidates
from other countries have been recommended.
To deal with this controversy, we adapted a hospice/
palliative need assessment form (Table 1) from the St
Mary’s Medical Center Palliative Care Screening Tool. Ourform includes five categories: the main diagnosis with life-
threatening impact, the comorbidities, the current func-
tional status (Eastern Co-operative Oncology Group scale),
the miscellaneous conditions, and the surprise question. All
the chronic dialysis patients in NTUH-JS dialysis units
received a formal assessment using this form, and those
with scores higher than 5 were offered the choice of
entering into our RSC subprogram. Interfacility palliative
care coordination between NTUH-JS, NTUH main branch,
and primary care clinics also exists to maximize patient
identification and recruitment (Figure 3).
Step one: home-based family visit
After the identification of suitable RSC candidates, we
conducted family visits (FVs) for all of them on an annual
basis. There are several advantages offered by FVs for
chronic dialysis patients; first, psychosocial factors,
including the health interference of social activities, the
dissatisfaction with family and staffs, and the sense of
isolation occur in more than one-half of ESRD patients,
correlating significantly with their QoL.41,42 FV has been
found to improve the communication between family
members and patients, and ameliorate patients’ psycho-
logical suffering.43,44 We found that patient satisfaction
improved significantly after our FVs, and the rapport
gained during FVs could be helpful in arranging subsequent
family meetings and EOL discussions. Second, EOL care
involves the designation of the preferred place of death,
and a domestic study found that 67% of the patients’ family
members chose home as the preferred place of death.45 In
a rural and mountainous area where NTUH-JS is located,
FVs can help physicians estimate the transport time be-
tween the patient residences and the dialysis units, if the
patients wish to receive RSC in hospital-based settings.
Finally, FVs enable physicians to understand more thor-
oughly the symptom burdens of these patients. ESRD pa-
tients, despite their diverse symptomatology, often fail to
disclose in detail how they feel to physicians or other staff
members in the dialysis units. Consequently, an opportu-
nity to walk into patients’ lives increases the willingness of
physicians to show more empathy, facilitating the subse-
quent introduction of the RSC concept.
Step two: home-based family meeting in an open
atmosphere
Self-reported knowledge of renal palliative care is poor
among CKD and ESRD patients, and only 12e22% of patients
understand the meaning and implications of palliative/
hospice care.40,46 Even in developed countries, more than
90% of CKD and ESRD patients are unaware of their illness
trajectories, despite the fact that most participants wish to
know their medical conditions and prognosis.46 Further-
more, 80% of CKD/ESRD patients rely on nephrologists for
obtaining health information, and 66e70% feel comfortable
in EOL discussions with their family members. These find-
ings point out the importance of involving family members
and nephrologists in a successful RSC program.
Home-based palliative care is often used in clinical
settings, but home-based family meeting for RSC is rarely
Table 1 National Taiwan University Hospital Jinshan branch hospice/palliative care assessment form.
Abbreviations: ARDS, adult respiratory distress syndrome; Cat, Category; COPD, chronic obstructive pulmonary disease; MOF,
multi-organ failure.
Figure 3 The geographic location of NTUH-JS hospital and the residential sites of dialysis patients covered by NTUH-JS. NTUH-
JSZ National Taiwan University Hospital Jinshan branch.
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discussions in a separate room during dialysis or in an in-
dividual clinic, compared to those held in dialysis units.46
In Taiwan, dialysis units are less spacious than those in
other countries, and patient could easily overhear the
words from others during the talk. Lack of privacy could be
a critical but under-ecognized factor in determining
whether an EOL discussion will succeed. In our home-based
RSC program, we test the feasibility for nephrologists to
share prognostic and EOL information with candidates at
their home, where patients are expectedly more relaxed
and open-minded.
The location in which the EOL discussion takes place is
important. Literature suggests that the hospital setting
likely plays a role in influencing patients’ perceptions.47
Although counseling held in individual clinics is more pref-
erable than in dialysis units, patients facing the disclosure
of a poor prognosis tend to be emotionally unstable. In such
cases, a familiar space, along with the presence of their
loved ones, could ease their uneasiness, reducing the ten-
sion that might emerge without proper environmental
setup. In addition, nephrologists can provide recommen-
dations for home preparation if RSC is deemed appropriate.
An open atmosphere is also required for a successful EOL
discussion. Traditionally, family meetings involve schedules
set in advance with all parties. Although meetings arranged
according to standardized protocols can decrease tension,
the lack of flexibility in such circumstances might defer
decision-making by patients or family members during the
EOL talk.30 The privacy and sense of ease offered by home-
based family meeting could reduce the conflict and
enhance the patients/family’s willingness to consider all
possible scenarios, even the worse ones.Step three: postdecision EOL care
Decision phase
Once the patients or their proxies decide upon receiving RSC,
patients then enter into the first of the four stages of EOL
care for renal patients (Figure 4). The four stagesdthe de-
cision, the stabilization, the near-death, and the bereave-
ment phasesdeach contain different goals of care. In the
decision phase, the content of RSC will be explained in
detail, along with prognosis estimation and conflict resolu-
tion, all of which take several rounds of family meetings to
achieve. Informed consent will be sought if patients are
competent, assisted by folk communicators and/or village
heads; otherwise, a patient proxy, supported by family
members, will be designated after family meetings. We will
also inquire about the acceptability of DNR, and explain
about the pros and cons of aggressive resuscitation. Ne-
phrologists, patients, and their family members will reach a
conclusion on the appropriate timing of RSC implementation
(dialysis withdrawal or withhold). Finally, advanced care
planning constitutes another important issue in this phase.
Stabilization phase
The stabilization phase is a symptom-free period lasting
from days to as long as weeks after RSC is initiated
(Figure 4). Symptoms of cutis, respiratory, or gastrointes-
tinal tract are reduced to a minimal level with optimally
adjusted medications. Oral intake or intravenous fluid can
be given ad libitum, according to patients’ wishes and
tolerability. This phase offers time and opportunity for
renal patients to do what they have been longing for but
have never accomplished before, assisted by family mem-
bers and dedicated staff members.
Figure 4 (A) The four phases of EOL care for patients receiving RSC at terminal status. (B) The component of the interdisciplinary
team aiming to offer “daily home visit” for RSC patients. RSCZ renal supportive care.
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In the near-death phase, patients receiving RSC begin to
show dying symptoms from uremia, fluid overload, cardio-
vascular events, or infections. Symptom-reliever dosages
are increased per patients’ or family’s request. Patients are
allowed to stay at home if possible, or hospitalized infre-
quently; they have the opportunity to express their grati-
tude toward their family, friends, or medical staff. In the
NTUH-JS experience, we organize an institute-wide inter-
disciplinary team to conduct the “daily home visit,” aiming
to ameliorate family anxiety, to offer timely advice and
explanation on patient care, and to estimate the required
dosage of symptom-relief medications (Figure 4). The
number of team members should be large enough to satisfy
the staff capacity required for daily visits; the team
members need not be physicians, and could include medi-
cal personnels of other specialties and even folk volunteers
after training in the palliative/hospice care. An uninter-
rupted companion with patient/family by medical staff can
significantly console their mind and empower them to
embrace the dying patients. The “daily home visit” con-
tinues until the day patients pass away peacefully.
Bereavement phase
After the near-death phase, the bereavement phase en-
sues, and family members are given advice about religious
activities. Clinical psychologists provide periodic small-group counseling sessions for the family, and the family
members are invited to join hospital-held events if they
agree. We recognize that EOL care does not stop even if
patients pass away; bereavement counseling for the
remaining family members is another important step to
complete the map of EOL care.
Current status and implications for the future
Between 2012 and 2015, we have screened 54 chronic
dialysis patients in NTUH-JS, and eight patients were
deemed appropriate for RSC, nearly three-fourths of whom
received dialysis withdrawal/withhold smoothly (Table
2).48 After the successful implementation of the RSC sub-
program at NTUH-JS, we have learned several lessons.
First, family members are decision-makers in 80% of cases,
echoing the “family-centered decision-making model” in
Taiwanese society.26 Second, the major concern of rural
Taiwanese patients receiving RSC and their family is
whether there is any subjective discomfort among these
patients, rather than patient survival. Finally, in a rural
area such as Jinshan district, the socioeconomic factor
seems to play a relatively more important role than in the
urban area, interfering with patients’ willingness to choose
RSC or chronic dialysis. This should also be taken into
consideration during the first step of information sharing as
detailed above.







Decision maker RSC settings Survival
duration a
Main issues of concern by
patients or family members
Case 1 75 F Taoism CKD stage 5D 3 y Family members Community-based 7 d 1. Repeated hospitaliza-
tions with deconditioning
2. Sepsis
Case 2 80 F Taoism CKD stage 5 Not yet Patient Community-based 3 d (from
discharge)
1. Subjective discomfort
2. Balancing between avail-
ability of long-term care
and the burden on her
family
Case 3 90 F Taoism Acute on CKD
(stage IIIb)
Not yet Family members Community-based 4 d (from
diagnosis)
1. Subjective discomfort
Case 4 77 F Taoism CKD stage 5D 10 y Family members Community-based 7 d 1. Subjective discomfort
2. Severe functional
limitation
3. Poor survival from
advanced esophageal
cancer
Case 5 55 M None CKD stage 5D 2 y Patient and
Family
members
Community-based 3 d 1. Subjective discomfort
2. Poor survival from gastric
cancer with multiple
metastases
CKDZ chronic kidney disease; NTUHZ National Taiwan University Hospital.
Note. From “Incorporating palliative care into the dialysis unit affects patterns near the end of life,” by C.F. Lai, S.H. Hsu and S.J.
Huang, 2015, Mayo Clin Proc, 90, p. 1307e9. Copyright 2015, Elsevier Inc. Partly adapted with permission.
a After dialysis withdrawal or withhold.
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prognostic information for those who are elderly, have low
educational levels, and are less cognitively competent. The
prognostic models recommended by different professional
societies can be too complicated for rural residents to un-
derstand. We are currently investigating whether we could
introduce the concept of frailty into our RSC program.49
Frailty denotes a phenotype of age-associated physical and
functional decline in the elderly, and the prevalence of
frailty in CKD/ESRDpatients is high. The presence of frailty in
CKD/ESRD patients is associated with cardiovascular events
and poor outcomes.50,51 The frequent coexistence of frailty
and CKD/ESRD might be an important hinge that we can levy
when explaining prognosis, because frailty is often explicit in
appearance. However, further research is still needed.
Conclusion
Initiating a successful RSC program is often thought to be
difficult in Taiwanese society, and the complex sociocultural
inherent issue is an important concern. Through the three-
step and four-phase RSC infrastructure, we attempt to
confront this dilemma and the progress is fair so far.
Although the case number is still low, we believe a wider
application of our approach could improve the feasibility of
RSC in Taiwan.
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